{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:52:23Z","timestamp":1791561143605,"version":"4.3.4"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR076900"],"award-info":[{"award-number":["R01AR076900"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS070328"],"award-info":[{"award-number":["R01NS070328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR062207"],"award-info":[{"award-number":["R01AR062207"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR078035"],"award-info":[{"award-number":["R01AR078035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS070328"],"award-info":[{"award-number":["R01NS070328"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR076900"],"award-info":[{"award-number":["R01AR076900"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR062207"],"award-info":[{"award-number":["R01AR062207"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR078035"],"award-info":[{"award-number":["R01AR078035"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cytogfr.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T17:08:00Z","timestamp":1767719280000},"page":"18-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["cPLA2 in musculoskeletal and autoimmune diseases: Molecular mechanisms and therapeutic insights"],"prefix":"10.1016","volume":"88","author":[{"given":"Chaopeng","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiwu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-ju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10055","key":"10.1016\/j.cytogfr.2026.01.002_bib1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"9991","key":"10.1016\/j.cytogfr.2026.01.002_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis","volume":"386","author":"Glyn-Jones","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrrheum.2013.160","article-title":"Role of cytokines in intervertebral disc degeneration: pain and disc content","volume":"10","author":"Risbud","year":"2014","journal-title":"Nat. Rev. Rheuma"},{"issue":"10191","key":"10.1016\/j.cytogfr.2026.01.002_bib4","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","article-title":"Sarcopenia","volume":"393","author":"Cruz-Jentoft","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.002_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.mcna.2021.05.016","article-title":"Update on osteoporosis screening and management","volume":"105","author":"Anam","year":"2021","journal-title":"Med. Clin. North Am."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib6","first-page":"54","article-title":"Insights into the underlying pathogenesis and therapeutic potential of endoplasmic reticulum stress in degenerative musculoskeletal diseases","volume":"10","author":"Wen","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.753931","article-title":"Interactions Among lncRNA\/circRNA, miRNA, and mRNA in Musculoskeletal Degenerative Diseases","volume":"9","author":"Zheng","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.002_bib8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/03009742.2010.547872","article-title":"Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage","volume":"40","author":"Leistad","year":"2011","journal-title":"Scand. J. Rheuma"},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.002_bib9","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2019-215543","article-title":"Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis","volume":"78","author":"Liu","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bbrc.2009.11.070","article-title":"Phospholipase A2-derived lysophosphatidylcholine triggers Ca2+ entry in dystrophic skeletal muscle fibers","volume":"391","author":"Boittin","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12035-024-04290-6","article-title":"Underlying Mechanism of Lysosomal Membrane Permeabilization in CNS Injury: a Literature Review","volume":"62","author":"Xiang","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12974-025-03606-0","article-title":"SIK2 mediated mitochondrial homeostasis in spinal cord injury: modulating oxidative stress and the AIM2 inflammasome via CRTC1\/CREB signaling","volume":"22","author":"Fang","year":"2025","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.002_bib13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.7150\/ijbs.57825","article-title":"Betulinic acid inhibits pyroptosis in spinal cord injury by augmenting autophagy via the AMPK-mTOR-TFEB signaling pathway","volume":"17","author":"Wu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cytogfr.2023.11.001","article-title":"Progranulinopathy: a diverse realm of disorders linked to progranulin imbalances","volume":"76","author":"Huang","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib15","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib16","doi-asserted-by":"crossref","DOI":"10.4103\/NRR.NRR-D-25-00701","article-title":"Akkermansia muciniphila: A next-generation gut probiotic supporting neurorepair and functional recovery","author":"Yuan","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"13","key":"10.1016\/j.cytogfr.2026.01.002_bib17","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.lfs.2007.08.018","article-title":"Implication of cytosolic phospholipase A2 (cPLA2) in the regulation of human synoviocyte NADPH oxidase (Nox2) activity","volume":"81","author":"Chenevier-Gobeaux","year":"2007","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.002_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ecco-jcc\/jjv094","article-title":"Diet-induced hyperhomocysteinaemia increases intestinal inflammation in an animal model of colitis","volume":"9","author":"Zhu","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/279171","article-title":"HO-1 induction by CO-RM2 attenuates TNF-alpha-induced cytosolic phospholipase A2 expression via inhibition of PKCalpha-dependent NADPH oxidase\/ROS and NF-kappaB","volume":"2014","author":"Chi","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.002_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1302\/2046-3758.117.BJR-2021-0594.R1","article-title":"Immunomodulatory role of T helper cells in rheumatoid arthritis: a comprehensive research review","volume":"11","author":"Luo","year":"2022","journal-title":"Bone Jt. Res."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.002_bib21","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cell.2019.11.016","article-title":"Metabolic control of astrocyte pathogenic activity via cPLA2-MAVS","volume":"179","author":"Chao","year":"2019","journal-title":"Cell"},{"issue":"Pt 5","key":"10.1016\/j.cytogfr.2026.01.002_bib22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/brain\/awp002","article-title":"Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis","volume":"132","author":"Kalyvas","year":"2009","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.002_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.20050665","article-title":"Cytosolic phospholipase A2\u03b1\u2013deficient mice are resistant to experimental autoimmune encephalomyelitis","volume":"202","author":"Marusic","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e130210","article-title":"A study of the correlation between phospholipase A2 enzyme activity and anti-complement antibodies in patients with systemic lupus erythematosus","volume":"71","author":"Cholakova","year":"2024","journal-title":"Pharmacia"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.002_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021353","article-title":"The Phospholipase A2 Superfamily: structure, isozymes, catalysis, physiologic and pathologic roles","volume":"24","author":"Khan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.002_bib26","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2025.13468","article-title":"Research progress of cPLA2 in cardiovascular diseases (Review)","volume":"31","author":"Lin","year":"2025","journal-title":"Mol. Med. Rep."},{"issue":"45","key":"10.1016\/j.cytogfr.2026.01.002_bib27","doi-asserted-by":"crossref","first-page":"31227","DOI":"10.1074\/jbc.M804492200","article-title":"A phospholipid substrate molecule residing in the membrane surface mediates opening of the lid region in group IVA cytosolic phospholipase A2","volume":"283","author":"Burke","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.002_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0092-8674(00)80744-8","article-title":"Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism","volume":"97","author":"Dessen","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41537-024-00474-0","article-title":"Copy number deletion of PLA2G4A affects the susceptibility and clinical phenotypes of schizophrenia","volume":"10","author":"Gao","year":"2024","journal-title":"Schizophrenia"},{"issue":"1-2","key":"10.1016\/j.cytogfr.2026.01.002_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1388-1981(00)00108-6","article-title":"Structure and mechanism of human cytosolic phospholipase A(2)","volume":"1488","author":"Dessen","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13024-022-00549-5","article-title":"Calcium-dependent cytosolic phospholipase A(2) activation is implicated in neuroinflammation and oxidative stress associated with ApoE4","volume":"17","author":"Wang","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.002_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0092-8674(93)90666-E","article-title":"cPLA2 is phosphorylated and activated by MAP kinase","volume":"72","author":"Lin","year":"1993","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.cytogfr.2026.01.002_bib33","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood.2022015568","article-title":"MAPK-interacting kinase 1 regulates platelet production, activation, and thrombosis","volume":"140","author":"Manne","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.freeradbiomed.2024.02.016","article-title":"The ERK-cPLA2-ACSL4 axis mediating M2 macrophages ferroptosis impedes mucosal healing in ulcerative colitis","volume":"214","author":"Ye","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.002_bib35","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI13210","article-title":"Arachidonic acid as a bioactive molecule","volume":"107","author":"Brash","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.002_bib36","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.002_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1483","article-title":"Oncogenic PIK3CA recruits myeloid-derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5-lipoxygenase-dependent arachidonic acid pathway","volume":"13","author":"Li","year":"2023","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semcancer.2016.02.001","article-title":"Targeting arachidonic acid pathway by natural products for cancer prevention and therapy","volume":"40-41","author":"Yarla","year":"2016","journal-title":"Semin Cancer Biol."},{"issue":"15","key":"10.1016\/j.cytogfr.2026.01.002_bib39","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-20-4245","article-title":"Intravital Imaging Identifies the VEGF-TXA(2) Axis as a Critical Promoter of PGE(2) Secretion from Tumor Cells and Immune Evasion","volume":"81","author":"Konishi","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s13046-021-02118-y","article-title":"Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma","volume":"40","author":"Cioce","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12974-023-02690-4","article-title":"Elamipretide alleviates pyroptosis in traumatically injured spinal cord by inhibiting cPLA2-induced lysosomal membrane permeabilization","volume":"20","author":"Zhang","year":"2023","journal-title":"J. Neuroinflamm."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.01.002_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.459","article-title":"Dual role of the p38 MAPK\/cPLA2 pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists","volume":"4","author":"Rukoyatkina","year":"2013","journal-title":"Cell Death Dis."},{"issue":"2-3","key":"10.1016\/j.cytogfr.2026.01.002_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1388-1981(02)00326-8","article-title":"Phospolipase A2 and apoptosis","volume":"1585","author":"Taketo","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.002_bib44","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1080\/15548627.2021.2002109","article-title":"Inhibition of PLA2G4E\/cPLA2 promotes survival of random skin flaps by alleviating Lysosomal membrane permeabilization-Induced necroptosis","volume":"18","author":"Lou","year":"2022","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.002_bib45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1432-1033.1996.t01-1-00533.x","article-title":"Different apoptotic pathways mediated by Fas and the tumor-necrosis-factor receptor. Cytosolic phospholipase A2 is not involved in Fas-mediated apoptosis","volume":"236","author":"Enari","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.002_bib46","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1006\/cyto.1999.0505","article-title":"Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signalling pathways in human OA synovial fibroblasts","volume":"11","author":"Alaaeddine","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102518","article-title":"Lipid hydroperoxides and oxylipins are mediators of denervation induced muscle atrophy","volume":"57","author":"Brown","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102761","article-title":"Elevated phospholipid hydroperoxide glutathione peroxidase (GPX4) expression modulates oxylipin formation and inhibits age-related skeletal muscle atrophy and weakness","volume":"64","author":"Czyzowska","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.freeradbiomed.2013.10.002","article-title":"Genetic ablation of 12\/15-lipoxygenase but not 5-lipoxygenase protects against denervation-induced muscle atrophy","volume":"67","author":"Bhattacharya","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2561929","article-title":"Interactions between Cytosolic Phospholipase A2 Activation and Mitochondrial Reactive Oxygen Species Production in the Development of Ventilator-Induced Diaphragm Dysfunction","volume":"2019","author":"Zhou","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.002_bib51","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.bbalip.2014.10.004","article-title":"Phospholipase A2 regulation of lipid droplet formation","volume":"1841","author":"Guijas","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105201","article-title":"Therapeutic potential of cPLA2 inhibitor to counteract dilated-cardiomyopathy in cholesterol-treated H9C2 cardiomyocyte and MUNO rat","volume":"160","author":"Huang","year":"2020","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.002_bib53","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","article-title":"The senescence-associated secretory phenotype and its physiological and pathological implications","volume":"25","author":"Wang","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41413-025-00470-9","article-title":"Cytosolic phospholipase A2 as a therapeutic target for degenerative joint diseases","volume":"13","author":"Huang","year":"2025","journal-title":"Bone Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.002_bib55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1302\/2046-3758.102.BJR-2020-0228.R1","article-title":"The function of lncRNAs in the pathogenesis of osteoarthritis","volume":"10","author":"He","year":"2021","journal-title":"Bone Jt. Res."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105303","article-title":"Tagitinin F has anti-inflammatory, anti-nociceptive and anti-matrix metalloproteinase properties: an in silico, in vitro and in vivo study","volume":"164","author":"Silva","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101113","article-title":"Potential modulatory mechanisms of action by long-chain polyunsaturated fatty acids on bone cell and chondrocyte metabolism","volume":"83","author":"Abshirini","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.114987","article-title":"Tanshinone IIA suppresses burning incense-induced oxidative stress and inflammatory pathways in astrocytes","volume":"258","author":"Chi","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib59","doi-asserted-by":"crossref","unstructured":"Z.L. Dong, X. Jiao, Z.G. Wang, K. Yuan, Y.Q. Yang, Y. Wang, D-mannose alleviates intervertebral disc degeneration through glutamine metabolism 1 11 Mil. Med. Res.2024, 28.","DOI":"10.1186\/s40779-024-00529-4"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41413-024-00373-1","article-title":"KMT2A regulates the autophagy-GATA4 axis through METTL3-mediated m(6)A modification of ATG4a to promote NPCs senescence and IVDD progression","volume":"12","author":"Wu","year":"2024","journal-title":"Bone Res."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s005860050095","article-title":"Comparative immunohistochemical study of group II (synovial-type) and group IV (cytosolic) phospholipases A2 in disc prolapse tissue","volume":"7","author":"Habtemariam","year":"1998","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib62","article-title":"Fexofenadine Protects Against Intervertebral Disc Degeneration Through TNF Signaling","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib63","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00007632-199007000-00011","article-title":"High Levels of Inflammatory Phospholipase A2 Activity in Lumbar Disc Herniations","volume":"15","author":"Saal","year":"1990","journal-title":"Spine"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib64","doi-asserted-by":"crossref","DOI":"10.1097\/00007632-199206001-00011","article-title":"Human Disc Phospholipase A2 is Inflammatory","volume":"17","author":"Franson","year":"1992","journal-title":"Spine"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.002_bib65","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.joca.2025.02.783","article-title":"Beta-defensin 1 knockdown ameliorates the characteristics of intervertebral disc degeneration by altering nucleus pulposus and annulus fibrosus cell phenotypes via suppression of the extracellular signal-regulated kinase signaling pathway","volume":"33","author":"Wei","year":"2025","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13018-025-05577-7","article-title":"Targeting skeletal interoception: a novel mechanistic insight into intervertebral disc degeneration and pain management","volume":"20","author":"Zhu","year":"2025","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib67","first-page":"258","article-title":"Functions and mechanisms of cytosolic phospholipase A2 in central nervous system trauma","volume":"18","author":"Zhang","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib68","article-title":"Multiomics analysis reveals the potential of LPCAT1-PC axis as a therapeutic target for human intervertebral disc degeneration","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.002_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/jsp2.70062","article-title":"Phosphatidylcholine Ameliorates Palmitic Acid-Induced Lipotoxicity by Facilitating Endoplasmic Reticulum and Mitochondria Contacts in Intervertebral Disc Degeneration","volume":"8","author":"Tu","year":"2025","journal-title":"JOR Spine"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.002_bib70","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1039\/D0FO00884B","article-title":"The opposite effects of Antarctic krill oil and arachidonic acid-rich oil on bone resorption in ovariectomized mice","volume":"11","author":"Zhan","year":"2020","journal-title":"Food Funct."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.002_bib71","first-page":"1598","article-title":"Role of EP3 and EP4 prostaglandin receptors in reorganization of the cytoskeleton in mature human osteoclasts","volume":"31","author":"Sarrazin","year":"2004","journal-title":"J. Rheuma"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.002_bib72","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.plefa.2013.12.009","article-title":"Cytosolic phospholipase A2 and eicosanoids modulate life, death and function of human osteoclasts in vitro","volume":"90","author":"Allard-Chamard","year":"2014","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib73","article-title":"Phospholipase D1 activity is crucial for cytosolic phospholipase A(2) -dependent prostaglandin E(2) formation in murine osteoblastic MC3T3-E1 cells","volume":"198-199","author":"Leis","year":"2023","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10930-014-9594-6","article-title":"Molecular characterisation of group IVA (cytosolic) phospholipase A2 in murine osteoblastic MC3T3-E1 cells","volume":"34","author":"Leis","year":"2015","journal-title":"Protein J."},{"issue":"32","key":"10.1016\/j.cytogfr.2026.01.002_bib75","doi-asserted-by":"crossref","first-page":"19891","DOI":"10.1074\/jbc.272.32.19891","article-title":"Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2","volume":"272","author":"Murakami","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.002_bib76","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1074\/jbc.272.9.5952","article-title":"Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1","volume":"272","author":"Chen","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.002_bib77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s000110050566","article-title":"Augmented prostaglandin E2 generation resulting from increased activities of cytosolic and secretory phospholipase A2 and induction of cyclooxygenase-2 in interleukin-1 beta-stimulated rat calvarial cells during the mineralizing phase","volume":"49","author":"Higashi","year":"2000","journal-title":"Inflamm. Res"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsbmb.2014.09.019","article-title":"Membrane actions of 1alpha,25(OH)2D3 are mediated by Ca(2+)\/calmodulin-dependent protein kinase II in bone and cartilage cells","volume":"145","author":"Doroudi","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"24","key":"10.1016\/j.cytogfr.2026.01.002_bib79","doi-asserted-by":"crossref","first-page":"21920","DOI":"10.1074\/jbc.M204598200","article-title":"Leptin induces apoptosis via ERK\/cPLA2\/cytochrome c pathway in human bone marrow stromal cells","volume":"278","author":"Kim","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.002_bib80","doi-asserted-by":"crossref","first-page":"C1152","DOI":"10.1152\/ajpcell.00322.2003","article-title":"Role of mitochondrial superoxide dismutase in contraction-induced generation of reactive oxygen species in skeletal muscle extracellular space","volume":"286","author":"McArdle","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.002_bib81","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2990.2007.00798.x","article-title":"Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach","volume":"33","author":"Pierno","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.002_bib82","doi-asserted-by":"crossref","first-page":"R1173","DOI":"10.1152\/ajpregu.00735.2009","article-title":"Regulatory interactions between muscle and the immune system during muscle regeneration","volume":"298","author":"Tidball","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.002_bib83","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nm0502-480","article-title":"A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis","volume":"8","author":"Nagase","year":"2002","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.002_bib84","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1440-1681.2006.04394.x","article-title":"Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species","volume":"33","author":"Whitehead","year":"2006","journal-title":"Clin. Exp. Pharm. Physiol."},{"issue":"3-4","key":"10.1016\/j.cytogfr.2026.01.002_bib85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.plefa.2007.10.002","article-title":"Effects of inhibitors of the arachidonic acid cascade on primary muscle culture from a Duchenne muscular dystrophy patient","volume":"77","author":"Gati","year":"2007","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib86","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/76897","article-title":"Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2","volume":"1","author":"Nagase","year":"2000","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.002_bib88","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0960-8966(94)00045-B","article-title":"Phospholipase A2 activity in dystrophinopathies","volume":"5","author":"Lindahl","year":"1995","journal-title":"Neuromuscul. Disord."},{"issue":"Pt 18","key":"10.1016\/j.cytogfr.2026.01.002_bib89","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1242\/jcs.03184","article-title":"Ca2+-independent phospholipase A2 enhances store-operated Ca2+ entry in dystrophic skeletal muscle fibers","volume":"119","author":"Boittin","year":"2006","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.002_bib90","doi-asserted-by":"crossref","first-page":"177S","DOI":"10.1042\/bst019177s","article-title":"Prostaglandin metabolism in dystrophin-deficient MDX mouse muscle","volume":"19","author":"McArdle","year":"1991","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1212\/WNL.41.1.101","article-title":"Creatine kinase and prostaglandin E2 release from isolated Duchenne muscle","volume":"41","author":"Jackson","year":"1991","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.002_bib92","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135703","article-title":"TGF-beta-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model","volume":"5","author":"Mazala","year":"2020","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.002_bib93","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41574-018-0150-x","article-title":"Circadian rhythms and exercise - re-setting the clock in metabolic disease","volume":"15","author":"Gabriel","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbadis.2016.09.006","article-title":"Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE)","volume":"1863","author":"Pena","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.002_bib95","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.cmet.2016.04.001","article-title":"Mapping the human platelet lipidome reveals cytosolic phospholipase A2 as a regulator of mitochondrial bioenergetics during activation","volume":"23","author":"Slatter","year":"2016","journal-title":"Cell Metab."},{"issue":"5 Pt B","key":"10.1016\/j.cytogfr.2026.01.002_bib96","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.bbadis.2017.07.019","article-title":"Lipid droplet proteins and metabolic diseases","volume":"1864","author":"Xu","year":"2018","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.002_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202411559","article-title":"Mechanical Activation of cPLA2 Impedes Fatty Acid \u03b2-Oxidation in Vein Grafts","volume":"12","author":"Fan","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib98","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1038\/s41467-021-22431-6","article-title":"Prostaglandin in the ventromedial hypothalamus regulates peripheral glucose metabolism","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00018-023-05078-y","article-title":"Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney","volume":"81","author":"Hou","year":"2024","journal-title":"Cell Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.002_bib100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/jnc.14318","article-title":"Mitochondrial dysfunction in human skeletal muscle biopsies of lipid storage disorder","volume":"145","author":"Debashree","year":"2018","journal-title":"J. Neurochem."},{"issue":"24","key":"10.1016\/j.cytogfr.2026.01.002_bib101","doi-asserted-by":"crossref","first-page":"25219","DOI":"10.1074\/jbc.M310381200","article-title":"Arachidonic acid released by phospholipase A(2) activation triggers Ca(2+)-dependent apoptosis through the mitochondrial pathway","volume":"279","author":"Penzo","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.002_bib102","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/jnnp.36.2.174","article-title":"Physiological changes in ageing muscles","volume":"36","author":"Campbell","year":"1973","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1474-9728.2003.00011.x","article-title":"Neural control of aging skeletal muscle","volume":"2","author":"Delbono","year":"2003","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029082","article-title":"Denervation causes fiber atrophy and myosin heavy chain co-expression in senescent skeletal muscle","volume":"7","author":"Rowan","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70792-7","article-title":"Targeting cPLA(2) derived lipid hydroperoxides as a potential intervention for sarcopenia","volume":"10","author":"Pharaoh","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib106","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1074\/jbc.M806311200","article-title":"Denervation induces cytosolic phospholipase A2-mediated fatty acid hydroperoxide generation by muscle mitochondria","volume":"284","author":"Bhattacharya","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib107","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85289","article-title":"Lipid hydroperoxides promote sarcopenia through carbonyl stress","volume":"12","author":"Eshima","year":"2023","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib108","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.002_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083555","article-title":"Cytosolic phospholipase A2 regulates TNF-induced production of joint destructive effectors in synoviocytes","volume":"8","author":"Sommerfelt","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.cytogfr.2026.01.002_bib110","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1016\/j.cell.2024.07.014","article-title":"Neutrophil trapping and nexocytosis, mast cell-mediated processes for inflammatory signal relay","volume":"187","author":"Mihlan","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114152","article-title":"IRGM\/Irgm1 deficiency inhibits neutrophil-platelet interactions and thrombosis in experimental atherosclerosis and arterial injury","volume":"158","author":"Sun","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"17","key":"10.1016\/j.cytogfr.2026.01.002_bib112","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138443","article-title":"Epigenetic regulation of the PGE2 pathway modulates macrophage phenotype in normal and pathologic wound repair","volume":"5","author":"Davis","year":"2020","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105561","article-title":"Leukotriene B4 receptor 2 governs macrophage migration during tissue inflammation","volume":"300","author":"Ermis","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib114","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","article-title":"Environmental triggers in IBD: a review of progress and evidence","volume":"15","author":"Ananthakrishnan","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.002_bib115","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11373-006-9083-9","article-title":"Plant originated glycoprotein has anti-oxidative and anti-inflammatory effects on dextran sulfate sodium-induced colitis in mouse","volume":"13","author":"Oh","year":"2006","journal-title":"J. Biomed. Sci."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.002_bib116","first-page":"1170","article-title":"Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease","volume":"92","author":"Hendel","year":"1997","journal-title":"Am. J. Gastroenterol."},{"issue":"3-4","key":"10.1016\/j.cytogfr.2026.01.002_bib117","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1098-8823(03)00038-8","article-title":"Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats","volume":"71","author":"Singh","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.002_bib118","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1128\/IAI.00407-08","article-title":"Distinct isoforms of phospholipase A2 mediate the ability of Salmonella enterica serotype typhimurium and Shigella flexneri to induce the transepithelial migration of neutrophils","volume":"76","author":"Mumy","year":"2008","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.01.002_bib119","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jcmgh.2022.09.002","article-title":"Neutrophil-Epithelial Crosstalk During Intestinal Inflammation","volume":"14","author":"Kang","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib120","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1007\/s10620-024-08588-2","article-title":"Homocysteine Promotes Intestinal Inflammation in Colitis Mice Through the PGE2\/STAT3 Signaling Pathway","volume":"69","author":"Shao","year":"2024","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.01.002_bib121","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/eji.201545848","article-title":"Cytosolic phospholipase A2 \u03b1 has a crucial role in the pathogenesis of DSS-induced colitis in mice","volume":"46","author":"Rosengarten","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.002_bib122","article-title":"Exogenous pyruvate is therapeutic against colitis by targeting cytosolic phospholipase A2","volume":"12","author":"Hasan","year":"2025","journal-title":"Genes Dis."},{"issue":"20","key":"10.1016\/j.cytogfr.2026.01.002_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011155","article-title":"Cytosolic Phospholipase A2 Is Required for Fexofenadine's Therapeutic Effects against Inflammatory Bowel Disease in Mice","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10136","key":"10.1016\/j.cytogfr.2026.01.002_bib124","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.cytogfr.2026.01.002_bib125","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151911","article-title":"Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris","volume":"6","author":"Shao","year":"2021","journal-title":"JCI Insight"},{"issue":"10188","key":"10.1016\/j.cytogfr.2026.01.002_bib126","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.01.002_bib127","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.20020542","article-title":"I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation","volume":"196","author":"Kim","year":"2002","journal-title":"J. Exp. Med."},{"issue":"20","key":"10.1016\/j.cytogfr.2026.01.002_bib128","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.2022.14236","article-title":"What Is Multiple Sclerosis?","volume":"328","author":"Marcus","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0896-6273(04)00003-0","article-title":"Cytosolic Phospholipase A2 Plays a Key Role in the Pathogenesis of Multiple Sclerosis-like Disease","volume":"41","author":"Kalyvas","year":"2004","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.002_bib130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0896-6273(04)00003-0","article-title":"Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease","volume":"41","author":"Kalyvas","year":"2004","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-84936-6","article-title":"Cytosolic phospholipase A2 in infiltrating monocyte derived macrophages does not impair recovery after spinal cord injury in female mice","volume":"15","author":"Glaser","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib132","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.msard.2018.10.115","article-title":"The role of phospholipase A2 in multiple Sclerosis: a systematic review and meta-analysis","volume":"27","author":"Trotter","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.cytogfr.2026.01.002_bib133","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/890139","article-title":"Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis","volume":"2014","author":"Yang","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"Pt 3","key":"10.1016\/j.cytogfr.2026.01.002_bib134","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1042\/bj3630727","article-title":"Characterization of a novel inhibitor of cytosolic phospholipase A2alpha, pyrrophenone","volume":"363","author":"Ono","year":"2002","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.01.002_bib135","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuropharm.2010.11.025","article-title":"The cPLA2alpha inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluid","volume":"60","author":"Nickerson-Nutter","year":"2011","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.002_bib136","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/jm701467e","article-title":"Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-3-[5-chloro-2-(2-[(3,4-dichlorobenzyl)sulfonyl]aminoethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propylbenzoic acid, efipladib","volume":"51","author":"McKew","year":"2008","journal-title":"J. Med. Chem."},{"issue":"47","key":"10.1016\/j.cytogfr.2026.01.002_bib137","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.1021\/bi00210a002","article-title":"NMR structural studies of the tight complex between a trifluoromethyl ketone inhibitor and the 85-kDa human phospholipase A2","volume":"32","author":"Trimble","year":"1993","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.cytogfr.2026.01.002_bib138","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1021\/bi00074a003","article-title":"Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2","volume":"32","author":"Street","year":"1993","journal-title":"Biochemistry"},{"issue":"20","key":"10.1016\/j.cytogfr.2026.01.002_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207528","article-title":"Activation of the VEGF-A\/ERK\/PLA2 Axis Mediates Early Retinal Endothelial Cell Damage Induced by High Glucose: New Insight from an In Vitro Model of Diabetic Retinopathy","volume":"21","author":"Giurdanella","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.01.002_bib140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125638","article-title":"Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment","volume":"4","author":"Schanstra","year":"2019","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.01.002_bib141","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1097\/01.tp.0000226065.82066.21","article-title":"Cytosolic phospholipase A2 inhibition attenuates ischemia-reperfusion injury in an isolated rat lung model","volume":"81","author":"Bellido-Reyes","year":"2006","journal-title":"Transplantation"},{"issue":"16-18","key":"10.1016\/j.cytogfr.2026.01.002_bib142","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1089\/ars.2024.0794","article-title":"Development of Calcium-Dependent Phospholipase A2 Inhibitors to Target Cellular Senescence and Oxidative Stress in Neurodegenerative Diseases","volume":"41","author":"Hugo","year":"2024","journal-title":"Antioxid. Redox Signal"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.01.002_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543770903463905","article-title":"Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases","volume":"20","author":"Magrioti","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.01.002_bib144","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1021\/acsomega.8b01214","article-title":"Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A(2) (GIVA cPLA(2))","volume":"3","author":"Psarra","year":"2018","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.01.002_bib145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1124\/jpet.118.255034","article-title":"AK106-001616, a Potent and Selective Inhibitor of Cytosolic Phospholipase A(2): In Vivo Efficacy for Inflammation, Neuropathic Pain, and Pulmonary Fibrosis","volume":"369","author":"Shimizu","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.01.002_bib146","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/00498254.2014.1000430","article-title":"Evaluation of drug-drug interaction between the novel cPLA2 inhibitor AK106-001616 and methotrexate in rheumatoid arthritis patients","volume":"45","author":"Kozaki","year":"2015","journal-title":"Xenobiotica"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.01.002_bib147","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/procel\/pwae014","article-title":"Dietary pyruvate targets cytosolic phospholipase A2 to mitigate inflammation and obesity in mice","volume":"15","author":"Hasan","year":"2024","journal-title":"Protein Cell"},{"key":"10.1016\/j.cytogfr.2026.01.002_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2025.101571","article-title":"Exogenous pyruvate is therapeutic against colitis by targeting cytosolic phospholipase A2","author":"Hasan","year":"2025","journal-title":"Genes Dis."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961012600002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961012600002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:03:28Z","timestamp":1773968608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135961012600002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":148,"alternative-id":["S135961012600002X"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.01.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"cPLA2 in musculoskeletal and autoimmune diseases: Molecular mechanisms and therapeutic insights","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}